[
  {
    "title": "Bristol-Myers Squibb to buy Peninsula heart drug maker for $13.1 billion - San Francisco Business Times",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Bristol-Myers Squibb to buy Peninsula heart drug maker for $13.1 billion - San Francisco Business Times"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.bizjournals.com/sanfrancisco/news/2020/10/05/bristol-myers-squibb-myokardia-bmy-myok-heart-hcm.html"
      }
    ],
    "link": "https://www.bizjournals.com/sanfrancisco/news/2020/10/05/bristol-myers-squibb-myokardia-bmy-myok-heart-hcm.html",
    "id": "52781102840921",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 15:10:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      15,
      10,
      0,
      0,
      279,
      0
    ],
    "summary": "<ol><li><a href=\"https://www.bizjournals.com/sanfrancisco/news/2020/10/05/bristol-myers-squibb-myokardia-bmy-myok-heart-hcm.html\" target=\"_blank\">Bristol-Myers Squibb to buy Peninsula heart drug maker for $13.1 billion</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">San Francisco Business Times</font></li><li><a href=\"https://www.investing.com/news/stock-market-news/bristolmyers-to-buy-heart-drugs-developer-myokardia-for-about-13-billion-2315535\" target=\"_blank\">Bristol Myers expands heart drug business with $13 billion deal for MyoKardia</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com</font></li><li><a href=\"https://realmoney.thestreet.com/investing/stocks/does-aggressive-bristol-myers-have-the-right-prescription-for-investors--15449628\" target=\"_blank\">Does 'Aggressive' Bristol-Myers Have the Right Prescription for Investors?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">RealMoney</font></li><li><a href=\"https://www.pharmalive.com/bms-strengthens-cardiovascular-business-with-13-1-billion-myokardia-buyout/\" target=\"_blank\">BMS Strengthens Cardiovascular Business with $13.1 Billion MyoKardia Buyout</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PharmaLive</font></li><li><a href=\"https://www.ajmc.com/view/what-we-re-reading-examining-a-covid-19-vaccine-bms-acquires-myokardia-heath-it-in-rural-communities\" target=\"_blank\">What We're Reading: Examining a COVID-19 Vaccine; BMS Acquires MyoKardia; Heath IT in Rural Communities</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AJMC.com Managed Markets Network</font></li><li><strong><a href=\"https://news.google.com/stories/CAAqOQgKIjNDQklTSURvSmMzUnZjbmt0TXpZd1NoTUtFUWpaLUlyM2tJQU1FVjIwaVRFTksyZ0ZLQUFQAQ?oc=5\" target=\"_blank\">View Full Coverage on Google News</a></strong></li></ol>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<ol><li><a href=\"https://www.bizjournals.com/sanfrancisco/news/2020/10/05/bristol-myers-squibb-myokardia-bmy-myok-heart-hcm.html\" target=\"_blank\">Bristol-Myers Squibb to buy Peninsula heart drug maker for $13.1 billion</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">San Francisco Business Times</font></li><li><a href=\"https://www.investing.com/news/stock-market-news/bristolmyers-to-buy-heart-drugs-developer-myokardia-for-about-13-billion-2315535\" target=\"_blank\">Bristol Myers expands heart drug business with $13 billion deal for MyoKardia</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com</font></li><li><a href=\"https://realmoney.thestreet.com/investing/stocks/does-aggressive-bristol-myers-have-the-right-prescription-for-investors--15449628\" target=\"_blank\">Does 'Aggressive' Bristol-Myers Have the Right Prescription for Investors?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">RealMoney</font></li><li><a href=\"https://www.pharmalive.com/bms-strengthens-cardiovascular-business-with-13-1-billion-myokardia-buyout/\" target=\"_blank\">BMS Strengthens Cardiovascular Business with $13.1 Billion MyoKardia Buyout</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PharmaLive</font></li><li><a href=\"https://www.ajmc.com/view/what-we-re-reading-examining-a-covid-19-vaccine-bms-acquires-myokardia-heath-it-in-rural-communities\" target=\"_blank\">What We're Reading: Examining a COVID-19 Vaccine; BMS Acquires MyoKardia; Heath IT in Rural Communities</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AJMC.com Managed Markets Network</font></li><li><strong><a href=\"https://news.google.com/stories/CAAqOQgKIjNDQklTSURvSmMzUnZjbmt0TXpZd1NoTUtFUWpaLUlyM2tJQU1FVjIwaVRFTksyZ0ZLQUFQAQ?oc=5\" target=\"_blank\">View Full Coverage on Google News</a></strong></li></ol>"
    },
    "source": {
      "href": "https://www.bizjournals.com",
      "title": "San Francisco Business Times"
    },
    "sub_articles": [
      {
        "url": "https://www.bizjournals.com/sanfrancisco/news/2020/10/05/bristol-myers-squibb-myokardia-bmy-myok-heart-hcm.html",
        "title": "Bristol-Myers Squibb to buy Peninsula heart drug maker for $13.1 billion",
        "publisher": "San Francisco Business Times"
      },
      {
        "url": "https://www.investing.com/news/stock-market-news/bristolmyers-to-buy-heart-drugs-developer-myokardia-for-about-13-billion-2315535",
        "title": "Bristol Myers expands heart drug business with $13 billion deal for MyoKardia",
        "publisher": "Investing.com"
      },
      {
        "url": "https://realmoney.thestreet.com/investing/stocks/does-aggressive-bristol-myers-have-the-right-prescription-for-investors--15449628",
        "title": "Does 'Aggressive' Bristol-Myers Have the Right Prescription for Investors?",
        "publisher": "RealMoney"
      },
      {
        "url": "https://www.pharmalive.com/bms-strengthens-cardiovascular-business-with-13-1-billion-myokardia-buyout/",
        "title": "BMS Strengthens Cardiovascular Business with $13.1 Billion MyoKardia Buyout",
        "publisher": "PharmaLive"
      },
      {
        "url": "https://www.ajmc.com/view/what-we-re-reading-examining-a-covid-19-vaccine-bms-acquires-myokardia-heath-it-in-rural-communities",
        "title": "What We're Reading: Examining a COVID-19 Vaccine; BMS Acquires MyoKardia; Heath IT in Rural Communities",
        "publisher": "AJMC.com Managed Markets Network"
      }
    ]
  },
  {
    "title": "Myokardia Inc (NASDAQ:MYOK) Given Consensus Recommendation of \"Buy\" by Brokerages - MarketBeat",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Myokardia Inc (NASDAQ:MYOK) Given Consensus Recommendation of \"Buy\" by Brokerages - MarketBeat"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.marketbeat.com/instant-alerts/nasdaq-myok-consensus-analyst-rating-2020-10/"
      }
    ],
    "link": "https://www.marketbeat.com/instant-alerts/nasdaq-myok-consensus-analyst-rating-2020-10/",
    "id": "CBMiV2h0dHBzOi8vd3d3Lm1hcmtldGJlYXQuY29tL2luc3RhbnQtYWxlcnRzL25hc2RhcS1teW9rLWNvbnNlbnN1cy1hbmFseXN0LXJhdGluZy0yMDIwLTEwL9IBW2h0dHBzOi8vd3d3Lm1hcmtldGJlYXQuY29tL2luc3RhbnQtYWxlcnRzL25hc2RhcS1teW9rLWNvbnNlbnN1cy1hbmFseXN0LXJhdGluZy0yMDIwLTEwL2FtcC8",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 14:37:34 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      14,
      37,
      34,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.marketbeat.com/instant-alerts/nasdaq-myok-consensus-analyst-rating-2020-10/\" target=\"_blank\">Myokardia Inc (NASDAQ:MYOK) Given Consensus Recommendation of \"Buy\" by Brokerages</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.marketbeat.com/instant-alerts/nasdaq-myok-consensus-analyst-rating-2020-10/\" target=\"_blank\">Myokardia Inc (NASDAQ:MYOK) Given Consensus Recommendation of \"Buy\" by Brokerages</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>"
    },
    "source": {
      "href": "https://www.marketbeat.com",
      "title": "MarketBeat"
    },
    "sub_articles": []
  },
  {
    "title": "MyoKardia, Eidos Therapeutics leads healthcare gainers, Xtant Medical Holdings, Curis among major losers - Seeking Alpha",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "MyoKardia, Eidos Therapeutics leads healthcare gainers, Xtant Medical Holdings, Curis among major losers - Seeking Alpha"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://seekingalpha.com/news/3619836-myokardia-eidos-therapeutics-leads-healthcare-gainers-xtant-medical-holdings-curis-among"
      }
    ],
    "link": "https://seekingalpha.com/news/3619836-myokardia-eidos-therapeutics-leads-healthcare-gainers-xtant-medical-holdings-curis-among",
    "id": "CAIiEKc0dFiT72rw6cSR3LkowUoqFggEKg0IACoGCAowkqEGMJBZMMTouwY",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 14:59:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      14,
      59,
      0,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://seekingalpha.com/news/3619836-myokardia-eidos-therapeutics-leads-healthcare-gainers-xtant-medical-holdings-curis-among\" target=\"_blank\">MyoKardia, Eidos Therapeutics leads healthcare gainers, Xtant Medical Holdings, Curis among major losers</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://seekingalpha.com/news/3619836-myokardia-eidos-therapeutics-leads-healthcare-gainers-xtant-medical-holdings-curis-among\" target=\"_blank\">MyoKardia, Eidos Therapeutics leads healthcare gainers, Xtant Medical Holdings, Curis among major losers</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>"
    },
    "source": {
      "href": "https://seekingalpha.com",
      "title": "Seeking Alpha"
    },
    "sub_articles": []
  },
  {
    "title": "MyoKardia : Bristol Myers expands heart drug business with $13 bln deal for MyoKardia - marketscreener.com",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "MyoKardia : Bristol Myers expands heart drug business with $13 bln deal for MyoKardia - marketscreener.com"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.marketscreener.com/quote/stock/MYOKARDIA-INC-24749772/news/MyoKardia-Bristol-Myers-expands-heart-drug-business-with-13-bln-deal-for-MyoKardia-31482393/"
      }
    ],
    "link": "https://www.marketscreener.com/quote/stock/MYOKARDIA-INC-24749772/news/MyoKardia-Bristol-Myers-expands-heart-drug-business-with-13-bln-deal-for-MyoKardia-31482393/",
    "id": "CBMiowFodHRwczovL3d3dy5tYXJrZXRzY3JlZW5lci5jb20vcXVvdGUvc3RvY2svTVlPS0FSRElBLUlOQy0yNDc0OTc3Mi9uZXdzL015b0thcmRpYS1CcmlzdG9sLU15ZXJzLWV4cGFuZHMtaGVhcnQtZHJ1Zy1idXNpbmVzcy13aXRoLTEzLWJsbi1kZWFsLWZvci1NeW9LYXJkaWEtMzE0ODIzOTMv0gEA",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 15:14:46 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      15,
      14,
      46,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.marketscreener.com/quote/stock/MYOKARDIA-INC-24749772/news/MyoKardia-Bristol-Myers-expands-heart-drug-business-with-13-bln-deal-for-MyoKardia-31482393/\" target=\"_blank\">MyoKardia : Bristol Myers expands heart drug business with $13 bln deal for MyoKardia</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">marketscreener.com</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.marketscreener.com/quote/stock/MYOKARDIA-INC-24749772/news/MyoKardia-Bristol-Myers-expands-heart-drug-business-with-13-bln-deal-for-MyoKardia-31482393/\" target=\"_blank\">MyoKardia : Bristol Myers expands heart drug business with $13 bln deal for MyoKardia</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">marketscreener.com</font>"
    },
    "source": {
      "href": "https://www.marketscreener.com",
      "title": "marketscreener.com"
    },
    "sub_articles": []
  },
  {
    "title": "Should you invest in Square, Myokardia, Gilead Sciences, Docusign, or Carnival Corp? - PRNewswire",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Should you invest in Square, Myokardia, Gilead Sciences, Docusign, or Carnival Corp? - PRNewswire"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.prnewswire.com/news-releases/should-you-invest-in-square-myokardia-gilead-sciences-docusign-or-carnival-corp-301145705.html"
      }
    ],
    "link": "https://www.prnewswire.com/news-releases/should-you-invest-in-square-myokardia-gilead-sciences-docusign-or-carnival-corp-301145705.html",
    "id": "CBMihwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL3Nob3VsZC15b3UtaW52ZXN0LWluLXNxdWFyZS1teW9rYXJkaWEtZ2lsZWFkLXNjaWVuY2VzLWRvY3VzaWduLW9yLWNhcm5pdmFsLWNvcnAtMzAxMTQ1NzA1Lmh0bWzSAQA",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 14:35:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      14,
      35,
      0,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.prnewswire.com/news-releases/should-you-invest-in-square-myokardia-gilead-sciences-docusign-or-carnival-corp-301145705.html\" target=\"_blank\">Should you invest in Square, Myokardia, Gilead Sciences, Docusign, or Carnival Corp?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PRNewswire</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.prnewswire.com/news-releases/should-you-invest-in-square-myokardia-gilead-sciences-docusign-or-carnival-corp-301145705.html\" target=\"_blank\">Should you invest in Square, Myokardia, Gilead Sciences, Docusign, or Carnival Corp?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PRNewswire</font>"
    },
    "source": {
      "href": "https://www.prnewswire.com",
      "title": "PRNewswire"
    },
    "sub_articles": []
  },
  {
    "title": "The Market Is a Feast of Opportunities - RealMoney",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "The Market Is a Feast of Opportunities - RealMoney"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://realmoney.thestreet.com/investing/the-market-is-a-feast-of-opportunities-15449592"
      }
    ],
    "link": "https://realmoney.thestreet.com/investing/the-market-is-a-feast-of-opportunities-15449592",
    "id": "CBMiWWh0dHBzOi8vcmVhbG1vbmV5LnRoZXN0cmVldC5jb20vaW52ZXN0aW5nL3RoZS1tYXJrZXQtaXMtYS1mZWFzdC1vZi1vcHBvcnR1bml0aWVzLTE1NDQ5NTky0gEA",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 14:34:16 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      14,
      34,
      16,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://realmoney.thestreet.com/investing/the-market-is-a-feast-of-opportunities-15449592\" target=\"_blank\">The Market Is a Feast of Opportunities</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">RealMoney</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://realmoney.thestreet.com/investing/the-market-is-a-feast-of-opportunities-15449592\" target=\"_blank\">The Market Is a Feast of Opportunities</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">RealMoney</font>"
    },
    "source": {
      "href": "https://realmoney.thestreet.com",
      "title": "RealMoney"
    },
    "sub_articles": []
  },
  {
    "title": "Top Penny Stocks To Watch Today If Biotech Is Your Focus - Penny Stocks",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Top Penny Stocks To Watch Today If Biotech Is Your Focus - Penny Stocks"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://pennystocks.com/featured/2020/10/05/top-penny-stocks-to-watch-today-biotech-focus-october-5-2020/"
      }
    ],
    "link": "https://pennystocks.com/featured/2020/10/05/top-penny-stocks-to-watch-today-biotech-focus-october-5-2020/",
    "id": "CBMiaWh0dHBzOi8vcGVubnlzdG9ja3MuY29tL2ZlYXR1cmVkLzIwMjAvMTAvMDUvdG9wLXBlbm55LXN0b2Nrcy10by13YXRjaC10b2RheS1iaW90ZWNoLWZvY3VzLW9jdG9iZXItNS0yMDIwL9IBAA",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 14:58:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      14,
      58,
      0,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://pennystocks.com/featured/2020/10/05/top-penny-stocks-to-watch-today-biotech-focus-october-5-2020/\" target=\"_blank\">Top Penny Stocks To Watch Today If Biotech Is Your Focus</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Penny Stocks</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://pennystocks.com/featured/2020/10/05/top-penny-stocks-to-watch-today-biotech-focus-october-5-2020/\" target=\"_blank\">Top Penny Stocks To Watch Today If Biotech Is Your Focus</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Penny Stocks</font>"
    },
    "source": {
      "href": "https://pennystocks.com",
      "title": "Penny Stocks"
    },
    "sub_articles": []
  },
  {
    "title": "Dow Jones Now Volatile a Month Out from the 2020 Election - Money Morning",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Dow Jones Now Volatile a Month Out from the 2020 Election - Money Morning"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://moneymorning.com/2020/10/05/dow-jones-now-volatile-a-month-out-from-the-2020-election/"
      }
    ],
    "link": "https://moneymorning.com/2020/10/05/dow-jones-now-volatile-a-month-out-from-the-2020-election/",
    "id": "CBMiXmh0dHBzOi8vbW9uZXltb3JuaW5nLmNvbS8yMDIwLzEwLzA1L2Rvdy1qb25lcy1ub3ctdm9sYXRpbGUtYS1tb250aC1vdXQtZnJvbS10aGUtMjAyMC1lbGVjdGlvbi_SAWJodHRwczovL21vbmV5bW9ybmluZy5jb20vMjAyMC8xMC8wNS9kb3ctam9uZXMtbm93LXZvbGF0aWxlLWEtbW9udGgtb3V0LWZyb20tdGhlLTIwMjAtZWxlY3Rpb24vYW1wLw",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 15:01:42 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      15,
      1,
      42,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://moneymorning.com/2020/10/05/dow-jones-now-volatile-a-month-out-from-the-2020-election/\" target=\"_blank\">Dow Jones Now Volatile a Month Out from the 2020 Election</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Money Morning</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://moneymorning.com/2020/10/05/dow-jones-now-volatile-a-month-out-from-the-2020-election/\" target=\"_blank\">Dow Jones Now Volatile a Month Out from the 2020 Election</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Money Morning</font>"
    },
    "source": {
      "href": "https://moneymorning.com",
      "title": "Money Morning"
    },
    "sub_articles": []
  },
  {
    "title": "Dow Up Nearly 400 Points on Optimism Over Trump's Health, Stimulus Hopes - TheStreet",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Dow Up Nearly 400 Points on Optimism Over Trump's Health, Stimulus Hopes - TheStreet"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.thestreet.com/markets/stock-market-today-dow-jones-industrial-average-trump-covid-100520"
      }
    ],
    "link": "https://www.thestreet.com/markets/stock-market-today-dow-jones-industrial-average-trump-covid-100520",
    "id": "CAIiEIuzkxnKofJKgCp5Nk1LhGkqFQgEKg0IACoGCAow8_0FMPBXMNniAg",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 14:57:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      14,
      57,
      0,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.thestreet.com/markets/stock-market-today-dow-jones-industrial-average-trump-covid-100520\" target=\"_blank\">Dow Up Nearly 400 Points on Optimism Over Trump's Health, Stimulus Hopes</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TheStreet</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.thestreet.com/markets/stock-market-today-dow-jones-industrial-average-trump-covid-100520\" target=\"_blank\">Dow Up Nearly 400 Points on Optimism Over Trump's Health, Stimulus Hopes</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TheStreet</font>"
    },
    "source": {
      "href": "https://www.thestreet.com",
      "title": "TheStreet"
    },
    "sub_articles": []
  },
  {
    "title": "Neil Kumar bets nearly $1B on what BridgeBio hopes will be their first big drug - Endpoints News",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Neil Kumar bets nearly $1B on what BridgeBio hopes will be their first big drug - Endpoints News"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://endpts.com/neil-kumar-bets-nearly-1b-on-what-bridgebio-hopes-will-be-their-first-big-drug/"
      }
    ],
    "link": "https://endpts.com/neil-kumar-bets-nearly-1b-on-what-bridgebio-hopes-will-be-their-first-big-drug/",
    "id": "CBMiYmh0dHBzOi8vZW5kcHRzLmNvbS9uZWlsLWt1bWFyLWJldHMtbmVhcmx5LTFiLW9uLXdoYXQtYnJpZGdlYmlvLWhvcGVzLXdpbGwtYmUtdGhlaXItZmlyc3QtYmlnLWRydWcv0gEA",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 15:00:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      15,
      0,
      0,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://endpts.com/neil-kumar-bets-nearly-1b-on-what-bridgebio-hopes-will-be-their-first-big-drug/\" target=\"_blank\">Neil Kumar bets nearly $1B on what BridgeBio hopes will be their first big drug</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://endpts.com/neil-kumar-bets-nearly-1b-on-what-bridgebio-hopes-will-be-their-first-big-drug/\" target=\"_blank\">Neil Kumar bets nearly $1B on what BridgeBio hopes will be their first big drug</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>"
    },
    "source": {
      "href": "https://endpts.com",
      "title": "Endpoints News"
    },
    "sub_articles": []
  },
  {
    "title": "Exxon to cut 1,600 jobs across Europe as oil rout weighs - Nasdaq",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Exxon to cut 1,600 jobs across Europe as oil rout weighs - Nasdaq"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.nasdaq.com/articles/exxon-to-cut-1600-jobs-across-europe-as-oil-rout-weighs-2020-10-05"
      }
    ],
    "link": "https://www.nasdaq.com/articles/exxon-to-cut-1600-jobs-across-europe-as-oil-rout-weighs-2020-10-05",
    "id": "CBMiYmh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvZXh4b24tdG8tY3V0LTE2MDAtam9icy1hY3Jvc3MtZXVyb3BlLWFzLW9pbC1yb3V0LXdlaWdocy0yMDIwLTEwLTA10gFmaHR0cHM6Ly93d3cubmFzZGFxLmNvbS9hcnRpY2xlcy9leHhvbi10by1jdXQtMTYwMC1qb2JzLWFjcm9zcy1ldXJvcGUtYXMtb2lsLXJvdXQtd2VpZ2hzLTIwMjAtMTAtMDU_YW1w",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 14:40:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      14,
      40,
      0,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.nasdaq.com/articles/exxon-to-cut-1600-jobs-across-europe-as-oil-rout-weighs-2020-10-05\" target=\"_blank\">Exxon to cut 1,600 jobs across Europe as oil rout weighs</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.nasdaq.com/articles/exxon-to-cut-1600-jobs-across-europe-as-oil-rout-weighs-2020-10-05\" target=\"_blank\">Exxon to cut 1,600 jobs across Europe as oil rout weighs</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>"
    },
    "source": {
      "href": "https://www.nasdaq.com",
      "title": "Nasdaq"
    },
    "sub_articles": []
  },
  {
    "title": "Stocks That Hit 52-Week Highs On Monday - Benzinga",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Stocks That Hit 52-Week Highs On Monday - Benzinga"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.benzinga.com/news/20/10/17784319/stocks-that-hit-52-week-highs-on-monday"
      }
    ],
    "link": "https://www.benzinga.com/news/20/10/17784319/stocks-that-hit-52-week-highs-on-monday",
    "id": "CBMiVGh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9uZXdzLzIwLzEwLzE3Nzg0MzE5L3N0b2Nrcy10aGF0LWhpdC01Mi13ZWVrLWhpZ2hzLW9uLW1vbmRhedIBAA",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 14:39:02 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      14,
      39,
      2,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.benzinga.com/news/20/10/17784319/stocks-that-hit-52-week-highs-on-monday\" target=\"_blank\">Stocks That Hit 52-Week Highs On Monday</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Benzinga</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.benzinga.com/news/20/10/17784319/stocks-that-hit-52-week-highs-on-monday\" target=\"_blank\">Stocks That Hit 52-Week Highs On Monday</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Benzinga</font>"
    },
    "source": {
      "href": "https://www.benzinga.com",
      "title": "Benzinga"
    },
    "sub_articles": []
  },
  {
    "title": "Stock Alert: Comtech Telecom Up 7% After Terminating Merger Deal With Gilat - Nasdaq",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Stock Alert: Comtech Telecom Up 7% After Terminating Merger Deal With Gilat - Nasdaq"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.nasdaq.com/articles/stock-alert%3A-comtech-telecom-up-7-after-terminating-merger-deal-with-gilat-2020-10-05"
      }
    ],
    "link": "https://www.nasdaq.com/articles/stock-alert%3A-comtech-telecom-up-7-after-terminating-merger-deal-with-gilat-2020-10-05",
    "id": "CAIiEF8Y1f_Z0Dw6P-BUdG9ktOsqMwgEKioIACIQT4VDYmxpaDN7y5JvscS9FioUCAoiEE-FQ2JsaWgze8uSb7HEvRYw6_HMBg",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 14:39:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      14,
      39,
      0,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.nasdaq.com/articles/stock-alert%3A-comtech-telecom-up-7-after-terminating-merger-deal-with-gilat-2020-10-05\" target=\"_blank\">Stock Alert: Comtech Telecom Up 7% After Terminating Merger Deal With Gilat</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.nasdaq.com/articles/stock-alert%3A-comtech-telecom-up-7-after-terminating-merger-deal-with-gilat-2020-10-05\" target=\"_blank\">Stock Alert: Comtech Telecom Up 7% After Terminating Merger Deal With Gilat</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>"
    },
    "source": {
      "href": "https://www.nasdaq.com",
      "title": "Nasdaq"
    },
    "sub_articles": []
  },
  {
    "title": "Stock Alert: GAN Rises 19% After Inking Ten-year Deal With Wynn Resorts - Nasdaq",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Stock Alert: GAN Rises 19% After Inking Ten-year Deal With Wynn Resorts - Nasdaq"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.nasdaq.com/articles/stock-alert%3A-gan-rises-19-after-inking-ten-year-deal-with-wynn-resorts-2020-10-05"
      }
    ],
    "link": "https://www.nasdaq.com/articles/stock-alert%3A-gan-rises-19-after-inking-ten-year-deal-with-wynn-resorts-2020-10-05",
    "id": "CAIiEPRTcMZVTOJO4HNJ9GiW6iwqMwgEKioIACIQT4VDYmxpaDN7y5JvscS9FioUCAoiEE-FQ2JsaWgze8uSb7HEvRYw6_HMBg",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 14:31:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      14,
      31,
      0,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.nasdaq.com/articles/stock-alert%3A-gan-rises-19-after-inking-ten-year-deal-with-wynn-resorts-2020-10-05\" target=\"_blank\">Stock Alert: GAN Rises 19% After Inking Ten-year Deal With Wynn Resorts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.nasdaq.com/articles/stock-alert%3A-gan-rises-19-after-inking-ten-year-deal-with-wynn-resorts-2020-10-05\" target=\"_blank\">Stock Alert: GAN Rises 19% After Inking Ten-year Deal With Wynn Resorts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>"
    },
    "source": {
      "href": "https://www.nasdaq.com",
      "title": "Nasdaq"
    },
    "sub_articles": []
  },
  {
    "title": "Cardiomyopathy Medication Market will touch a new level in upcoming year with Top Key Players like Pfizer, Roche, Sanofi, AstraZeneca, Merck - The Daily Chronicle",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Cardiomyopathy Medication Market will touch a new level in upcoming year with Top Key Players like Pfizer, Roche, Sanofi, AstraZeneca, Merck - The Daily Chronicle"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://thedailychronicle.in/news/2436096/cardiomyopathy-medication-market-will-touch-a-new-level-in-upcoming-year-with-top-key-players-like-pfizer-roche-sanofi-astrazeneca-merck/"
      }
    ],
    "link": "https://thedailychronicle.in/news/2436096/cardiomyopathy-medication-market-will-touch-a-new-level-in-upcoming-year-with-top-key-players-like-pfizer-roche-sanofi-astrazeneca-merck/",
    "id": "CBMiswFodHRwczovL3RoZWRhaWx5Y2hyb25pY2xlLmluL25ld3MvMjQzNjA5Ni9jYXJkaW9teW9wYXRoeS1tZWRpY2F0aW9uLW1hcmtldC13aWxsLXRvdWNoLWEtbmV3LWxldmVsLWluLXVwY29taW5nLXllYXItd2l0aC10b3Ata2V5LXBsYXllcnMtbGlrZS1wZml6ZXItcm9jaGUtc2Fub2ZpLWFzdHJhemVuZWNhLW1lcmNrL9IBAA",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 15:00:03 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      15,
      0,
      3,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://thedailychronicle.in/news/2436096/cardiomyopathy-medication-market-will-touch-a-new-level-in-upcoming-year-with-top-key-players-like-pfizer-roche-sanofi-astrazeneca-merck/\" target=\"_blank\">Cardiomyopathy Medication Market will touch a new level in upcoming year with Top Key Players like Pfizer, Roche, Sanofi, AstraZeneca, Merck</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Daily Chronicle</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://thedailychronicle.in/news/2436096/cardiomyopathy-medication-market-will-touch-a-new-level-in-upcoming-year-with-top-key-players-like-pfizer-roche-sanofi-astrazeneca-merck/\" target=\"_blank\">Cardiomyopathy Medication Market will touch a new level in upcoming year with Top Key Players like Pfizer, Roche, Sanofi, AstraZeneca, Merck</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Daily Chronicle</font>"
    },
    "source": {
      "href": "https://thedailychronicle.in",
      "title": "The Daily Chronicle"
    },
    "sub_articles": []
  },
  {
    "title": "AMC Entertainment Expected to Run Out of Liquidity Within 6 Months - Nasdaq",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "AMC Entertainment Expected to Run Out of Liquidity Within 6 Months - Nasdaq"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.nasdaq.com/articles/amc-entertainment-expected-to-run-out-of-liquidity-within-6-months-2020-10-05"
      }
    ],
    "link": "https://www.nasdaq.com/articles/amc-entertainment-expected-to-run-out-of-liquidity-within-6-months-2020-10-05",
    "id": "CBMibWh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvYW1jLWVudGVydGFpbm1lbnQtZXhwZWN0ZWQtdG8tcnVuLW91dC1vZi1saXF1aWRpdHktd2l0aGluLTYtbW9udGhzLTIwMjAtMTAtMDXSAXFodHRwczovL3d3dy5uYXNkYXEuY29tL2FydGljbGVzL2FtYy1lbnRlcnRhaW5tZW50LWV4cGVjdGVkLXRvLXJ1bi1vdXQtb2YtbGlxdWlkaXR5LXdpdGhpbi02LW1vbnRocy0yMDIwLTEwLTA1P2FtcA",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 14:44:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      14,
      44,
      0,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.nasdaq.com/articles/amc-entertainment-expected-to-run-out-of-liquidity-within-6-months-2020-10-05\" target=\"_blank\">AMC Entertainment Expected to Run Out of Liquidity Within 6 Months</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.nasdaq.com/articles/amc-entertainment-expected-to-run-out-of-liquidity-within-6-months-2020-10-05\" target=\"_blank\">AMC Entertainment Expected to Run Out of Liquidity Within 6 Months</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>"
    },
    "source": {
      "href": "https://www.nasdaq.com",
      "title": "Nasdaq"
    },
    "sub_articles": []
  },
  {
    "title": "U.S. Service Sector Growth Unexpectedly Accelerates In September - Nasdaq",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "U.S. Service Sector Growth Unexpectedly Accelerates In September - Nasdaq"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.nasdaq.com/articles/u.s.-service-sector-growth-unexpectedly-accelerates-in-september-2020-10-05"
      }
    ],
    "link": "https://www.nasdaq.com/articles/u.s.-service-sector-growth-unexpectedly-accelerates-in-september-2020-10-05",
    "id": "CAIiECgSOWxupbELAozoj9USASEqMwgEKioIACIQT4VDYmxpaDN7y5JvscS9FioUCAoiEE-FQ2JsaWgze8uSb7HEvRYw6_HMBg",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 14:45:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      14,
      45,
      0,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.nasdaq.com/articles/u.s.-service-sector-growth-unexpectedly-accelerates-in-september-2020-10-05\" target=\"_blank\">U.S. Service Sector Growth Unexpectedly Accelerates In September</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.nasdaq.com/articles/u.s.-service-sector-growth-unexpectedly-accelerates-in-september-2020-10-05\" target=\"_blank\">U.S. Service Sector Growth Unexpectedly Accelerates In September</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>"
    },
    "source": {
      "href": "https://www.nasdaq.com",
      "title": "Nasdaq"
    },
    "sub_articles": []
  },
  {
    "title": "US Stocks Rise on Signs of Muted Political Risk - Marketscreener.com",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "US Stocks Rise on Signs of Muted Political Risk - Marketscreener.com"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.marketscreener.com/news/latest/U-S-Stocks-Rise-on-Signs-of-Muted-Political-Risk--31484429/"
      }
    ],
    "link": "https://www.marketscreener.com/news/latest/U-S-Stocks-Rise-on-Signs-of-Muted-Political-Risk--31484429/",
    "id": "CAIiEH4RB1KIdFRqgrieLtGuIrkqGQgEKhAIACoHCAowxZ6VCzC-_6oDMMvTxQY",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 14:37:22 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      14,
      37,
      22,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.marketscreener.com/news/latest/U-S-Stocks-Rise-on-Signs-of-Muted-Political-Risk--31484429/\" target=\"_blank\">US Stocks Rise on Signs of Muted Political Risk</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Marketscreener.com</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.marketscreener.com/news/latest/U-S-Stocks-Rise-on-Signs-of-Muted-Political-Risk--31484429/\" target=\"_blank\">US Stocks Rise on Signs of Muted Political Risk</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Marketscreener.com</font>"
    },
    "source": {
      "href": "https://www.marketscreener.com",
      "title": "Marketscreener.com"
    },
    "sub_articles": []
  },
  {
    "title": "Why Centennial Resource Development Jumped 6% in Early Trading Today - Nasdaq",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Why Centennial Resource Development Jumped 6% in Early Trading Today - Nasdaq"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.nasdaq.com/articles/why-centennial-resource-development-jumped-6-in-early-trading-today-2020-10-05"
      }
    ],
    "link": "https://www.nasdaq.com/articles/why-centennial-resource-development-jumped-6-in-early-trading-today-2020-10-05",
    "id": "CBMibmh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvd2h5LWNlbnRlbm5pYWwtcmVzb3VyY2UtZGV2ZWxvcG1lbnQtanVtcGVkLTYtaW4tZWFybHktdHJhZGluZy10b2RheS0yMDIwLTEwLTA10gFyaHR0cHM6Ly93d3cubmFzZGFxLmNvbS9hcnRpY2xlcy93aHktY2VudGVubmlhbC1yZXNvdXJjZS1kZXZlbG9wbWVudC1qdW1wZWQtNi1pbi1lYXJseS10cmFkaW5nLXRvZGF5LTIwMjAtMTAtMDU_YW1w",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 14:36:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      14,
      36,
      0,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.nasdaq.com/articles/why-centennial-resource-development-jumped-6-in-early-trading-today-2020-10-05\" target=\"_blank\">Why Centennial Resource Development Jumped 6% in Early Trading Today</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.nasdaq.com/articles/why-centennial-resource-development-jumped-6-in-early-trading-today-2020-10-05\" target=\"_blank\">Why Centennial Resource Development Jumped 6% in Early Trading Today</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>"
    },
    "source": {
      "href": "https://www.nasdaq.com",
      "title": "Nasdaq"
    },
    "sub_articles": []
  },
  {
    "title": "SpaceX Challenge of Air Force Contract Dismissed by Judge - Nasdaq",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "SpaceX Challenge of Air Force Contract Dismissed by Judge - Nasdaq"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.nasdaq.com/articles/spacex-challenge-of-air-force-contract-dismissed-by-judge-2020-10-05"
      }
    ],
    "link": "https://www.nasdaq.com/articles/spacex-challenge-of-air-force-contract-dismissed-by-judge-2020-10-05",
    "id": "CBMiZGh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvc3BhY2V4LWNoYWxsZW5nZS1vZi1haXItZm9yY2UtY29udHJhY3QtZGlzbWlzc2VkLWJ5LWp1ZGdlLTIwMjAtMTAtMDXSAWhodHRwczovL3d3dy5uYXNkYXEuY29tL2FydGljbGVzL3NwYWNleC1jaGFsbGVuZ2Utb2YtYWlyLWZvcmNlLWNvbnRyYWN0LWRpc21pc3NlZC1ieS1qdWRnZS0yMDIwLTEwLTA1P2FtcA",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 14:36:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      14,
      36,
      0,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.nasdaq.com/articles/spacex-challenge-of-air-force-contract-dismissed-by-judge-2020-10-05\" target=\"_blank\">SpaceX Challenge of Air Force Contract Dismissed by Judge</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.nasdaq.com/articles/spacex-challenge-of-air-force-contract-dismissed-by-judge-2020-10-05\" target=\"_blank\">SpaceX Challenge of Air Force Contract Dismissed by Judge</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>"
    },
    "source": {
      "href": "https://www.nasdaq.com",
      "title": "Nasdaq"
    },
    "sub_articles": []
  }
]